Active JNJ Drug

Investigated by: K.N. Roy Chengappa · National Institutes of Health (NIH) · University of Pittsburgh · Virginia Commonwealth University

today NCT02230384 · Ph 2

2015201620172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 2	NCT02230384	Sep 2014 → Dec 2016	—	K.N. Roy Chengappa	Completed	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	Active JNJ Drug	ClinicalTrials.gov intervention name — accepted as the source's own label NCT02230384 ↗